BioSpace News Archive

Business

MDxHealth to Present First Quarter 2023 Financial Results on May 15

MDxHealth SA, a commercial-stage precision diagnostics company, announced it will release its financial results for the first quarter ended March 31, 2023, after market close on Monday, May 15, 2023.

May 1, 2023
·
1 min read
Business

Sientra to Report First Quarter 2023 Financial Results on May 11, 2023

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the first quarter of 2023 after the close of trading on Thursday, May 11, 2023.

May 1, 2023
·
1 min read
Business

Atea Pharmaceuticals to Host First Quarter 2023 Financial Results Conference Call on May 8, 2023

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”) today announced that it will host a live conference call and audio webcast on Monday, May 8, 2023, at 4:30 p.m. ET to report financial results for the first quarter ended March 31, 2023, and to provide a business update.

May 1, 2023
·
3 min read
Business

Revolution Medicines to Report Financial Results for First Quarter 2023 After Market Close on May 8, 2023

Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today announced that it will report financial results for the first quarter 2023 on Monday, May 8, 2023, after market close.

May 1, 2023
·
1 min read
Genetown

Editas Medicine Announces Publication in Nature Biotechnology of Comprehensive SLEEK Gene Editing Technology Data

Editas Medicine, Inc., a clinical stage genome editing company, announced that the journal Nature Biotechnology published the comprehensive data from a study of the proprietary SLEEK gene editing technology.

May 1, 2023
·
4 min read
Pharm Country

electroCore to Participate at Annual Aegis Virtual Conference

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, announced that electroCore’s Chief Executive Officer, Dan Goldberger, will present at the Annual Aegis Virtual Conference being held May 2-4, 2023.

May 1, 2023
·
1 min read
Business

CytomX Therapeutics to Report First Quarter 2023 Financial Results on May 9, 2023

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it will report first quarter financial results on Tuesday, May 9, 2023, after the close of U.S. markets.

May 1, 2023
·
2 min read
Biotech Bay

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 01, 2023

Cytokinetics, Incorporated announced that on April 28, 2023 it granted stock options to purchase an aggregate of 97,550 shares of common stock to 5 new employees, whose employment commenced in April 2023, as a material inducement to their employment.

May 1, 2023
·
3 min read
Business

Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, May 2, 2023, at 8:30 a.m. Eastern Time to report its first quarter 2023 financial results and recent portfolio execution.

May 1, 2023
·
1 min read
Business

Stryker reports first quarter 2023 operating results

Stryker reported operating results for the first quarter of 2023.

May 1, 2023
·
18 min read